Poster Rounds with the Professors

Poster Rounds with the Professors

Presentation Schedule

Below you will find the Presentation Schedule for the Poster Rounds with the Professors at the 2022 IGCS Meeting.
Please visit the page regularly as changes may occur. The presenting authors will be contacted directly in case of any changes.

Helpful Links and Resources: 

  • For guidelines on featured printed poster preparation, please click HERE.
  • For Poster Rounds session moderation guidelines, please click HERE.
  • For the onsite poster board allocation schedule, please click HERE.

11:25 - 11:55 AM

Poster Rounds with the Professors: Group E1
Professors: Diocesio Alves Pinto de Andrade, Brazil; Kohei Omatsu, Japan

  1. MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCERS USING AN INTEGRATIVE DNA SEQUENCING PANEL
    Presenter: Soyoun Rachel Kim, Canada
  2. ARE MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCER RECURRENCES MORE SALVAGEABLE THAN INTACT COHORT?
    Presenter: Soyoun Rachel Kim, Canada
  3. PROGNOSTIC RELEVANCE OF THE MOLECULAR BASED ESMO/ESTRO/ESP2020 RISK CLASSIFICATION IN ENDOMETRIAL CARCINOMA AFTER SURGICAL LYMPH NODE STAGING
    Presenter: Teresa Praetorius, Germany

 

Poster Rounds with the Professors: Group E2                                                                                                                                                                  Professor: Ramez Eskander, USA

  1. GENETIC TESTING FOLLOWING ABNORMAL IMMUNOHISTOCHEMISTRY RESULTS IN ENDOMETRIAL CANCER: A QUALITY IMPROVEMENT PROTOCOL
    Presenter: Hannah Karpel, USA
  2. INTEGRATED PROFILING OF A PROSPECTIVE ENDOMETRIAL CANCER ORGANOID BIOBANK REVEALS HIGH HETEROGENEITY
    Presenter: Hege Berg, Norway
  3. A CURRENT PERSPECTIVE ON ENDOMETRIAL CARCINOMA (EC) RISK CLASSIFICATION: RESULTS FROM AN EUROPEAN MULTICENTRE INITIATIVE.
    Presenter: Annika Rohner, Germany

 

Poster Rounds with the Professors: Group E3                                                                                                                                                                  Professors: Ana Oaknin, Spain; Angelica Nogueria Rodrigues, Brazil

  1. HORMONAL BIOMARKERS REMAIN PROGNOSTIC RELEVANT WITHIN THE MOLECULAR CLASSIFICATION IN ENDOMETRIAL CANCER
    Presenter: Stephanie Vrede, Netherlands
  2. IMMUNOMETABOLIC CHANGES DURING WEIGHT LOSS INDUCE TUMOR IMMUNOGENICITY RESULTING IN TUMOR REGRESSION
    Presenter: Martin Brennan, Ireland
  3. IMMUNE-RELATED ENDPOINTS IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER TREATED WITH DOSTARLIMAB IN THE GARNET STUDY
    Presenter: Ana Oaknin, Spain

1:25 - 1:55 PM

Poster Rounds with the Professors: Group E4                                                                                                                                                            Professors: Nicoleta Colombo, Italy; Amanda Nickles Fader, USA

  1. MOLECULAR LANDSCAPE OF ERBB2/HER2 GENE AMPLIFICATION AMONG PATIENTS WITH ENDOMETRIAL CARCINOMA.
    Presenter: Dimitrios Nasioudis, US
  2. IS REFLEX MLH1 PROMOTER HYPERMETHYLATION TESTING FOLLOWING MLH1 LOSS BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL CARCINOMA BEST PRACTICE?
    Presenter: Anna Plotkin, Canada
  3. MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS WITH SOLID TUMORS TREATED WITH DOSTARLIMAB IN THE GARNET STUDY
    Presenter: Susana Banerjee, UK

 

Poster Rounds with the Professors: Group E5                                                                                                                                                            Professors: Pamela Soliman, USA; Arthur Hsu, Taiwan

  1. SURVIVAL IMPACT OF ADJUVANT RADIOTHERAPY IN UTERINE CARCINOSARCOMA– A SEER BASED STUDY
    Presenter: Angela Jones, US
  2. PROCEDURAL INTERVENTIONS FOR OLIGOPROGRESSION DURING TREATMENT WITH IMMUNE CHECKPOINT BLOCKADE IN GYNECOLOGIC MALIGNANCIES
    Presenter: Tiffany Sia, US

11:55 AM - 12:25 PM

Poster Rounds with the Professors: Group C1                                                                                                                                                                Professors: Michelle Samora, Brazil; Jonathan Ledermann, UK

  1. ONCOLYTIC ADENOVIRUS MEM-288 ENCODING MEMBRANE-STABLE CD40L AND IFN BETA INDUCES AN ANTI-TUMOR IMMUNE RESPONSE IN A HIGH GRADE SEROUS OVARIAN CANCER MOUSE MODEL
    Presenter: Pamela Peters, US
  2. IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA
    Presenter: Junsik Park, South Korea
  3. ROLE OF GENOME-WIDE METHYLATION PROFILING OF CIRCULATING CELL-FREE DNA BY METHYLATED DNA SEQUENCING (MED-SEQ) IN ADVANCED-STAGE OVARIAN CANCER
    Presenter: Gatske Nieuwenhuyzen-de Boer, Netherlands

 

Poster Rounds with the Professors: Group C2                                                                                                                                                                        Professors: Domenica Larusso, Italy: Graziela Zibetti Dal Molin, Brazil;

  1. DOSE-DENSE, WEEKLY PACLITAXEL AND CARBOPLATIN WITH OR WITHOUT BEVACIZUMAB, IN METASTATIC OR RECURRENT CERVICAL CARCINOMA (FINAL ANALYSIS OF JCOG1311)
    Presenter: Mitsuya Ishikawa, Japan
  2. COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR FIRST-LINE TREATMENT IN PATIENTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER IN THE UNITED STATES
    Presenter: Bradley Monk, US
  3. THE PROGNOSTIC VALUE OF PRESENCE OF PELVIC AND/OR PARA-AORTIC LYMPH NODE METASTASES IN CERVICAL CANCER PATIENTS; INFLUENCE OF THE NEW FIGO CLASSIFICATION (STAGE IIIC)
    Presenter: Kim van Kol, Netherlands

 

Poster Rounds with the Professors: Group C3                                                                                                                                                                Professors: Nomonde Mbatani, South Africa; Dong-Hoon Suh, Korea

  1. THE DIAGNOSTIC ACCURACY OF COLPOSCOPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA 2+ AMONG HIV POSITIVE AND NEGATIVE SOUTH AFRICAN WOMEN.
    Presenter: Greta Dreyer, South Africa
  2. INTEGRATING CERVICAL CANCER SCREENING WITH VOLUNTARY FAMILY PLANNING IN MOZAMBIQUE: THE MULHER STUDY
    Presenter: Mila P. Salcedo,  US
  3. TISSUE-SPECIFIC METHYLATED DNA MARKER DISCRIMINATE AMONG ENDOMETRIAL, OVARIAN, AND CERVICAL CANCERS
    Presenter: Jessica Weng, US

1:55 - 2:25 PM

Poster Rounds with the Professors: Group C4                                                                                                                                                                        Profesors: David Gershenson, USA; Eduardo Paulino, Brazil

  1. FERTILITY-SPARING SURGERY IN STAGE I OVARIAN DYSGERMINOMA – THE ROLE OF SURGICAL AND RADIOLOGICAL STAGING
    Presenter: Diletta Fumagalli, Italy
  2. ONCOLOGIC OUTCOME OF PATIENTS WITH STAGE I IMMATURE TERATOMA TREATED WITH SURVEILLANCE OR ADJUVANT CHEMOTHERAPY
    Presenter: Giuseppe Marino, Italy
  3. THE IMPACT OF 2020 COVID-19 OUTBREAK ON THE TREATMENT PATTERNS OF CERVICAL CANCER IN BRAZILIAN PUBLIC HEALTH SYSTEM
    Presenter: Maria Amelia Borba, Brazil
  4. THE ROLE OF POSTOPERATIVE RADIATION AFTER RADICAL HYSTERECTOMY FOR WOMEN WITH EARLY-STAGE NEUROENDOCRINE CARCINOMA OF THE CERVIX: A META-ANALYSIS
    Presenter: Catherine Kim, US

 

Poster Rounds with the Professors: Group C5                                                                                                                                                                        Professors: Ritu Salani, USA; Agnaldo Lopes, Brazil

  1. PATTERNS OF PALLIATIVE CARE UTILIZATION BY WOMEN WITH GYNECOLOGIC MALIGNANCIES IN ONTARIO, CANADA: A 13-YEAR POPULATION-BASED RETROSPECTIVE ANALYSIS
    Presenter: Sarah J. Mah, Canada
  2. QUANTITY OVER EQUITY: DISPARITIES IN THE DISTRIBUTION OF THE U.S. GYNECOLOGIC ONCOLOGY WORKFORCE
    Presenter: Nerlyne Desravines, US
  3. ENHANCED RECOVERY AFTER SURGERY IN OPEN ABDOMINAL HYSTERECTOMY FOR MALIGNANT AND BENIGN DISEASE: A RANDOMISED CONTROL TRIAL
    Presenter: Shalini Rajaram, India

 

Poster Rounds with the Professors: Group O7                                                                                                                                                                        Professors: Roberto Angioli, Italy: Helen MacKay, Canada

  1. PREDICTION MODEL FOR COMPLETE CYTOREDUCTION AT PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN CANCER BY INTEGRATING OF 18F-FDG PET/CT PARAMETERS AND CA-125
    Presenter: Se Ik Kim, South Korea
  2. COST STUDY OF PLASMAJET SURGICAL DEVICE VERSUS CONVENTIONAL CYTOREDUCTIVE SURGERY IN ADVANCED-STAGE OVARIAN CANCER PATIENTS
    Presenter: Gatske Nieuwenhuyzen-de Boer, Netherlands

12:05 - 12:35 PM

Poster Rounds with the Professors: Group O1                                                                                                                                                                     Professors: Frederick Haynes Van de Merwe, South Africa; Bruno Azevedo, Brazil

  1. THE VALUE OF PET/CT FOR CYTOREDUCTIVE SURGERY SELECTION IN RECURRENT OVARIAN CARCINOMA
    Presenter: Glauco Baiocchi, Brazil
  2. PREOPERATIVE CT SCORE FOR PREDICTING COMPLETE GROSS RESECTION AT PRIMARY AND INTERVAL DEBULKING SURGERY OF ADVANCED OVARIAN CANCER DURING THE COVID19 PANDEMIC
    Presenter: Yun Wang, Norway

 

Poster Rounds with the Professors: Group O2                                                                                                                                                                          Professor: Mansoor Mirza, Denmark

  1. COST-EFFECTIVENESS OF HYSTERECTOMY AT THE TIME OF RISK-REDUCING BILATERAL SALPINGOOOPHORECTOMY FOR PATIENTS WITH BRCA1 MUTATIONS
    Presenter: Shayan Dioun, US
  2. TRENDS IN THE INCIDENCE OF OVARIAN GERM CELL CANCERS IN US ASIANS AND NATIVE CHINESE
    Presenter: Chinmayi Aryasomayajula, US
  3. TRENDS IN PHASE 3 CLINICAL TRIALS IN OVARIAN CANCER FROM 2001-2021
    Presenter: Arya Aliabadi, US

 

Poster Rounds with the Professors: Group O3                                                                                                                                                                      Professors: Isabelle Ray-Coquard, France; Linus Chuang, USA

  1. ASSESSING ROBUSTNESS OF AN ARTIFICIAL INTELLIGENCE DERIVED HISTOLOGICAL BIOMARKER ACROSS DIFFERENT SITES OF DISEASE AND IN SERIAL SECTIONS IN TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA
    Presenter: Anirudh Joshi, US
  2. PREDICTING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA USING AN ARTIFICIAL INTELLIGENCE HISTOPATHOLOGY PLATFORM
    Presenter: Anirudh Joshi, US
  3. HOMOLOGOUS RECOMBINATION DEFICIENCY AND CYCLIN E1 AMPLIFICATION ARE CORRELATED WITH IMMUNE CELL INFILTRATION AND SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER
    Presenter: Lilian van Wagensveld, Netherlands

2:05 - 2:35 PM

Poster Rounds with the Professors: Group O4                                                                                                                                                                 Professors: David O’Malley, USA; Andreia Melo, Brazil

  1. PHASE 2 RESULTS OF RELACORILANT + NAB-PACLITAXEL IN PATIENTS WITH RECURRENT, PLATINUM-RESISTANT OVARIAN CANCER WITH AND WITHOUT PRIOR BEVACIZUMAB
    Presenter: Nicoletta Colombo, Italy
  2. FIRST-LINE MAINTENANCE AMONG ADVANCED OVARIAN CANCER PATIENTS IN THE US ONCOLOGY NETWORK: A REAL-WORLD RETROSPECTIVE COHORT STUDY
    Presenter: Dana Chase, US
  3. MIRVETUXIMAB SORAVTANSINE AND CARBOPLATIN FOR TREATMENT OF PATIENTS WITH RECURRENT FOLATE RECEPTOR ALPHA-POSITIVE PLATINUM-SENSITIVE OVARIAN CANCER: A FINAL ANALYSIS
    Presenter: Kathleen Moore, US

 

Poster Rounds with the Professors: Group O5                                                                                                                                                                    Professors: Andreas Du Bois, Germany; Glauco Baiocchi, Brazil

  1. THE IMPACT OF UTILIZATION INDOCYANINE GREEN FOR ANASTOMOTIC PERFUSION ASSESSMENT ON THE RATE OF DIVERTING ILEOSTOMY IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Presenter: Lina Salman, Canada
  2. FIRST CLINICAL STUDY REPORTING ADOPTION OF ERAS IN CRS HIPEC AS PER PUBLISHED GUIDELINES: TIME TO ADOPT, EVOLVE & IMPROVE
    Presenter: Somashekhar SP, India

 

Poster Rounds with the Professors: Group O6                                                                                                                                                                 Professors: Jung-Yun Lee, Korea; Somashekhar SP, India

  1. PREDICTION OF PLATINUM-BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER USING APPARENT DIFFUSION COEFFICIENT OF MAGNETIC RESONANCE IMAGE AND MACHINE LEARNING ALGORITHM
    Presenter: Jae Yeon Woo, South Korea
  2. CRS-HIPEC IN UPFRONT VERSUS INTERVAL SETTING FOR ADVANCED EPITHELIAL OVARIAN CANCER – CUT WHEN FIT NOT WHEN FATIGUED
    Presenter: Somashekhar SP, India